Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)
Cash flows from operating activities:
Net loss	$ (20,387)	$ (53,710)
Adjustments to reconcile net loss to net cash provided by operating activities:
Change in allowance for doubtful accounts	2,995	241
Change in the fair value of acquisition-related contingent consideration	(5,494)	(1,276)
Amortization and write-off of deferred financing fees	582	2,912
Depreciation and amortization	36,146	34,463
Impairment loss - satellite network		31,224
Stock-based compensation	5,747	4,314
Foreign exchange loss	64	366
Deferred income taxes	(1,847)	758
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(14,490)	(18,010)
Inventories	5,554	(11,893)
Prepaid expenses and other assets	601	(4,156)
Accounts payable and accrued liabilities	(11,493)	8,929
Deferred revenue	1,687	(1,106)
Other liabilities	(595)	(262)
Net cash used in operating activities	(930)	(7,206)
Cash flows from investing activities:
Acquisition of business, net of cash acquired		(34,236)
Capital expenditures	(17,163)	(21,410)
Other	650	(650)
Net cash used in investing activities	(16,513)	(56,296)
Cash flows from financing activities:
Proceeds from public offering of common stock, net of underwriters’ discounts and commissions and offering costs of $1,705	27,967
Proceeds from private offering of common stock		15,000
Payment of long-term debt		(150,000)
Proceeds from issuance of long-term debt		250,000
Payments under revolving credit facility	(14,000)
Proceeds under revolving credit facility	14,000
Cash paid for debt issuance costs		(5,359)
Proceeds from issuance of common stock under employee stock purchase plan	668	529
Payment of deferred purchase consideration		(347)
Net cash provided by financing activities	28,635	109,823
Effect of exchange rate changes on cash and cash equivalents	(128)	568
Net increase in cash and cash equivalents, including restricted cash held for acquisition of $34,500 at September 30, 2017	11,064	46,889
Beginning of period	34,830	25,023
End of period	45,894	71,912
Cash paid for:
Interest	10,036	3,411
Income taxes	3,221	508
Noncash investing and financing activities:
Capital expenditures incurred not yet paid	332	725
Stock-based compensation related to capital expenditures	410	357
Series A convertible preferred stock dividend paid in-kind	11	12
Common stock issued as form of payment for MPUs	$ 827
Common stock issued in connection with the acquisition of businesses		764
Common stock issued as payment for contingent consideration		347
Acquisition-related contingent consideration		$ 9,835